Live Breaking News & Updates on Related disease

Stay updated with breaking news from Related disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zenas BioPharma Raises $200M in Series C Financing

Zenas BioPharma Raises $200M in Series C Financing
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Wellington , New-zealand-general- , New-zealand , Tim-xiao , Jake-nunn , Zenas-biopharma , Quan-venture-fund , Enavate-sciences , Norwest-venture-partners , Delos-capital , Longitude-capital , Federated-hermes-kaufmann-funds

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Menlo-park , California , United-states , San-francisco , India , Mumbai , Maharashtra , Rock-springs , Philadelphia

Canada is moving away from Pap tests. Here's what you need to know

Canada is now moving away from using Pap smears to screen for cervical cancer screening in favour of HPV, which is more effective and can be done at home.

Canada , United-kingdom , Prince-edward-island , British , Canadian , Brian-goldman , Craig-earle , Kim-alexander , Gina-ogilvie , Canada-research , Canadian-partnership-against-cancer , Canada-research-chair

Global Healthy Living Foundation to Present Pioneering Patient-Centered Research at ACR Convergence 2023

Global Healthy Living Foundation to Present Pioneering Patient-Centered Research at ACR Convergence 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France , Spain , Philadelphia , Pennsylvania , United-states , French , Spanish , Eileen-davidson , Kelly-gavigan , Susan-jara , Shilpa-venkatachalam , Laura-stradford

New ICD-10 Code is An Important Milestone for Rare Disease Patients

The introduction of an ICD-10 code specific to IgG4-Related Disease offers a promising opportunity to revolutionize patient care, enable more accurate diagnoses, and improve outcomes.

Massachusetts , United-states , United-kingdom , Casablanca , Grand-casablanca , Morocco , Japan , Japanese , Edwarda-fox , J-clin-rheumatol , Harvard-medical-school , World-health-organization

Alberta piloting at-home HPV test in hopes of reducing cervical cancer

5,000 home testing kits will go to under-screened populations such as those in rural or remote communities, Indigenous communities, and new immigrants. If the project is successful, provincewide implementation could begin next year, starting in May.

Canada , United-kingdom , British , Charlotte-taillon , Gina-ogilvie , Adriana-lagrange , Canada-research , Alberta-health , Bc-women-health-research-institute , University-of-british-columbia , Alberta-health-services , Health-research-institute

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obex

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Australia , South-korea , Japan , Singapore , Hong-kong , Taiwan , United-states , Zenas-biopharma , Coozenas-biopharma , Steve-sugino , Bristol-myers-squibb-company , Linkedin

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South-korea , Australia , Taiwan , United-states , Hong-kong , Singapore , Japan , Steigen , Baden-wüberg , Germany , Steve-sugino , Zenasbiopharmaand-linkedin

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD

Canada , New-york , United-states , Toronto , Ontario , Jake-edmiston , Edwarda-fox , Kevin-carmichael , Gabriel-friedman , John-stone , Zenas-biopharma , Postmedia-network-inc

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

United-states , John-stone , Zenas-biopharma , Edwarda-fox , Twitter , Zenas-biopharma-united-states , Professor-of-medicine-at-harvard-medical-school , Linkedin , Xencor-inc , Korea-bizwire , Lancet-rheumatology , Related-disease